Beauty And Fragrance Company Coty Expands Footprint With Global Stock Offering, Paris Listing
Beauty and fragrance company Coty Inc (NYSE: COTY) has disclosed its plans to initiate a global offering of 33 million of its Class A common stock.
Alibaba Board Announced That The Company Intends To Spin-off Cainiao By Way Of A Separate Listing Of The Cainiao Shares On The Main Board Of The Hong Kong Stock Exchange
The Board is pleased to announce that the Company intends to spin-off Cainiao by way of a separate listing of the Cainiao Shares on the Main Board of the Hong Kong Stock Exchange. The Company submitted a spin-off
Coty Inc. Launches Global Offering Of 33M Shares Of Class A Common Stock And Listing On The Professional Segment Of Euronext Paris; Expects Any Such Settlement To Occur Over Next 6 Months And In An Amount Not To Exceed 27M Shares
Coty Inc. (NYSE:COTY) ("Coty" or the "Company"), one of the world's largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, today announced the launch of a
Ainos Announces Placement Of Initial $3M Tranche Of $10M Private Placement; Proceeds To Fund Company’s Clinical Trials, Commercial Product Launch, And Working Capital; Initial Conversion Price Set At $1.50 Per Share
Proceeds to fund company's clinical trials, commercial product launch, and working capitalInitial conversion price set at $1.50 per shareSAN DIEGO, CA / ACCESSWIRE / September 25, 2023 / Ainos, Inc. (NASDAQ:AIMD,
Why Nio Shares Are Cratering Over 6% Premarket Today
Nio shares were sliding in premarket Monday amid broader market weakness and also rumors of a capital raise plan.
UAW Strikes Escalate Across GM, Stellantis Facilities Nationwide: Ford Not Involved
The United Auto Workers announced an expansion of strikes at 38 locations across 20 states Friday. These strikes…
Why Transcat Shares Are Sliding Today
Transcat Inc (NASDAQ: TRNS) shares are trading lower after the
Seelos Therapeutics Announces $4.5M Registered Direct Offering Of Common Stock And Warrants To Purchase Common Stock
Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) disorders and rare diseases, today announced that it
Akari Therapeutics Announces Existing Investors Support The Company Through A $2M Private Placement Financing, Company Also Receives $2.5M U.K. R&D Tax Credit
Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it has entered into
EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations
ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital.
ProSomnus's Executive Chair, CEO, and CFO are also participating in the financing.